Roche Xenical Diabetes Data Could Provide Reimbursement Opportunity

Roche Xenical four-year type II diabetes prevention data may help increase the number of patients who are reimbursed for the weight-loss drug

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet